Labviva is a life sciences purchasing and inventory platform that enhances transparency in supply chain and procurement processes.
Labviva has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in January 2025.
Labviva's investors include B Capital, Village Global, Glasswing Ventures, MassVentures, Biospring Partners.
Labviva is headquartered in Boston, United States.
Labviva is a life sciences purchasing and inventory platform that enhances transparency in supply chain and procurement processes.
Labviva is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Labviva — Funding & Investors." VCBacked, January 13, 2025, https://www.vcbacked.co/company/labviva. Accessed July 19, 2026.
VCBacked. (2025). Labviva — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/labviva
{{cite web |title=Labviva — Funding & Investors |url=https://www.vcbacked.co/company/labviva |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated